Clinical feasibility of accelerated whole liver water T1 mapping with T2*-compensation

Objective Current liver T1 mapping methods present restricted liver coverage, take long acquisition times, and mostly exclude the T1 bias induced by fat and iron effects. We evaluated the clinical feasibility of an accelerated water T1 (wT1) mapping method, including all liver segments, and the potential of its T2*-compensation (wT1comp) for fibrosis tissue assessment. Materials and methods Forty-three patients were classified into three groups: benign without/with risk of developing fibrosis and hepatocellular carcinoma (HCC). A 9‑slice accelerated single-shot spiral continuous inversion-recovery Look-Locker (CIR‑LL) wT1 mapping acquisition, performed in an 11‑s breath-hold, and clinical images (proton density fat fraction (PDFF), T2*, T1‑ and T2‑weighted) were acquired for all patients. ROIs were defined on the PDFF, T2* and wT1 maps in all liver segments. wT1comp was estimated based on the wT1–T2* correlation of the benign‑no‑risk group and was compared to wT1 and clinical images inspecting for fibrosis. Results For each patient group, wT1 maps presented broad liver coverage, capturing all liver segments. T2* and wT1 measurements of the benign‑no‑risk group were significantly correlated (wT1 = 12.78 × T2* + 481.45; r = 0.78; p < 0.001), and the T2*-compensation model was defined by wT1comp = wT1 − 12.78 × (T2* − 22). Liver segments of the same patient presented different wT1 values. Outperforming wT1, wT1comp identified 21 liver segments from nine patients associated with qualitative fibrosis findings in clinical images, some only visible in post‑contrast T1‑weighted images. Conclusion The wT1 method is feasible for fast, broad liver coverage in patients with HCC or benign lesions. The segment‑based wT1comp analysis shows potential for noninvasive, contrast‑free qualitative liver fibrosis assessment. Relevance statement The proposed water-specific T1 mapping method, its T2*-compensation, and the inclusion of all liver segments could be clinically relevant for the tissue-signal assessment of fibrotic liver segments without contrast-agent administration.